Supplements
This product scores high due to robust evidence from a well-designed RCT directly on the 5-strain blend, showing clinically meaningful reductions in postprandial glucose (32.5% spike reduction claimed) and near-significant A1C drop (0.6%), addressing key T2D markers unmet by many probiotics. Dosages align directionally with study (though study used 6 capsules/day vs product's 2), and strains target butyrate production and GLP-1 via gut restoration. Safety is excellent with no red flags in trials
Pendulum Glucose Control is a strong option for T2D patients seeking adjunct gut-based glucose support, backed by a solid RCT on its unique strain blend. Use under physician supervision with A1C monitoring after 3 months. Excellent for postprandial control where standard therapies fall short.